AXSOME THERAPEUTICS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+21.3% +$121M
$690M
Current Assets↑+21.4% +$104M
$589M
Cash & Equivalents↑+2.4% +$8M
$323M
Receivables↑+58.1% +$82M
$224M
Inventory↑+77.6% +$12M
$28M
Net PPE↓-3.8% -$22K
$562K
Goodwill↑+0.0% +$0
$12M
Intangibles↓-13.6% -$6M
$41M
Total Liabilities↑+17.6% +$90M
$602M
Current Liabilities↑+64.6% +$149M
$379M
Account Payables↓-9.0% -$6M
$66M
Long-Term Debt↓-34.8% -$63M
$118M
Stockholders Equity↑+54.9% +$31M
$88M
Retained Earnings↓-16.3% -$183M
$-1.31B
Operating Lease ROU Asset↑+287.5% +$15M
$21M
Operating Lease Liability↑+290.6% +$18M
$24M
Finance Lease ROU Asset↑+53.5% +$2M
$7M
Inventory Raw Materials↑+8.8% +$836K
$10M
Inventory WIP↑+130.9% +$10M
$18M
Inventory Finished Goods↑+25.5% +$2M
$11M
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
$180M
Debt Due Y5
$120M
Debt Due >Y5
$120M
Total Debt Carrying Amount↓-33.3% -$60M
$120M